Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Universal Starch-Chem Allied's earnings before interest and taxes (EBIT) for the
three
months ended in Mar. 2026 was ₹151 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹264 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Universal Starch-Chem Allied's annualizedROC % for the quarter that ended in Mar. 2026 was 23.92%.
Universal Starch-Chem Allied's annualizedROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 42.24%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Universal Starch-Chem Allied's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 20.27%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Agricultural Inputs subindustry, Universal Starch-Chem Allied's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Universal Starch-Chem Allied EV-to-EBIT vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Universal Starch-Chem Allied's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Universal Starch-Chem Allied's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹264 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Universal Starch-Chem Allied (BOM:524408) has a EBIT of ₹264 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Universal Starch-Chem Allied.
Is Universal Starch-Chem Allied's EBIT too high?
Universal Starch-Chem Allied's current EBIT is ₹264 Mil. Overall, Universal Starch-Chem Allied has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universal Starch-Chem Allied's EBIT compare to CTVA and CF?
Universal Starch-Chem Allied's EBIT of ₹264 Mil can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for an Agriculture company?
A good EBIT depends on the Agriculture industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Universal Starch-Chem Allied. Universal Starch-Chem Allied's current EBIT is ₹264 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universal Starch-Chem Allied stock overvalued right now?
Based on GuruFocus' analysis, Universal Starch-Chem Allied (BOM:524408) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹159.31, compared to a current price of ₹199.00 — trading 24.9% above its estimated fair value. The current EBIT is ₹264 Mil. Universal Starch-Chem Allied's overall GF Score™ is 58/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Universal Starch-Chem Allied (BOM:524408), the current EBIT is ₹264 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Universal Starch-Chem Allied (BOM:524408) Overvalued in 2026?
Based on GuruFocus' analysis, Universal Starch-Chem Allied stock appears to be overvalued.
The current stock price of ₹199.00 is trading 24.9% above its estimated GF Value™ of ₹159.31.
GuruFocus considers Universal Starch-Chem Allied to be Modestly Overvalued.
Key valuation signals for BOM:524408:
EBIT: ₹264 Mil
GF Value™: ₹159.31 vs. price of ₹199.00 (24.9% above fair value)
No single metric tells the full story. See the BOM:524408 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Universal Starch-Chem Allied Ltd is a manufacturer and exporter specializing in maize starch and its derivatives. The company operates in maize refining, producing products like starch powder, liquid glucose, dextrose monohydrate, dextrose anhydrous, and modified starches which serve various industries such as food, pharmaceuticals, textiles, paper, and adhesives. The company's operations are principally based in Maharashtra, India. Revenue is generated through the manufacturing and export of these starch-based products to a diverse set of domestic and international customers. Alongside its core starch business, the company engages in activities related to energy and environmental management, including bio-gas production and power generation via wind and co-generation plants.
58GF Score
Get the complete analysis for BOM:524408
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524408 has been successfully added to your 
